Clinical Trial

The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes

Study acronym: VOCircle
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 8, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Exhaled volatile organic compounds will be measured during daytime with the goal to identifying circadian variability. The study incudes three subgroups: people without diabetes, people with type 1 diabetes, and people with type 2 diabetes. A total of 60 people will be recruited for the study.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-08-02; most recent amendment 2025-12-01.
Status change: Active, Not Recruiting → Recruiting 2025-12-01
Status change: Recruiting → Active, Not Recruiting 2024-10-04
Trial Details
NCT Number NCT05984979
Lead Sponsor University of Bern
Collaborators: Insel Gruppe AG, University Hospital Bern, DCB Research AG
Conditions Diabetes Mellitus
Enrollment 60 participants
Start Date 2023-08-07
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-08